Pasar al contenido principal

DISEÑO DE NUEVAS RETROTRANSCRIPTASAS DEL VIH UTILES EN APLICACIONES BIOTECNOLOGICAS: MECANISMOS MOLECULARES DE CAMBIO DE MOLDE Y FORMACION DE EXTREMOS PROTUBERANTES DE ADN

BIO2016-76716-R

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Convocatoria Proyectos I+D+i Retos de Investigación
Año convocatoria 2016
Plan Estatal 2013-2016 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 5
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Peptides mimicking the β7/β8 loop of HIV'1 reverse transcriptase p51 as “hotspot-targeted” dimerization inhibitors

  • Sánchez-Murcia, Pedro A.
  • Castro, Sonia de
  • García-Aparicio, Carlos
  • Jiménez, M. Angeles
  • Corona, A.
  • Tramontano, Enzo
  • Sluis-Cremer, N.
  • Menéndez-Arias, Luis
  • Velázquez, Sonsoles
  • Gago, Federico
  • Camarasa Rius, María José
A conformationally constrained short peptide designed to target a protein−protein interaction hotspot in HIV-1 reverse transcriptase (RT) disrupts p66-p51 interactions and paves the way to the development of novel RT dimerization inhibitors., We are immensely grateful to Prof. Emeritus Jan Balzarini (KU Leuven) for his continuous example, support, and encouragement over the years. We are thankful to Prof. Antonio Jiménez’s lab members at UAH for collaboration and many helpful discussions. We thank the Spanish MINECO/MEC (project SAF20015-64629-C2 to M.J.C. and F.G.) and BIO2016-76716-R (to L.M.A.) for financial support. A Fundación Ramón Areces institutional grant to CBMSO is gratefully acknowledged. P.A.S.M. thanks the University of Vienna for allowing the use of its computational facilities.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Analysis and Molecular Determinants of HIV RNase H Cleavage Specificity at the PPT/U3 Junction

  • Álvarez, Mar
  • Sapena-Ventura, Enrique
  • Luczkowiak, Joanna
  • Martín-Alonso, Samara
  • Menéndez-Arias, Luis
© 2021 by the authors., HIV reverse transcriptases (RTs) convert viral genomic RNA into double-stranded DNA. During reverse transcription, polypurine tracts (PPTs) resilient to RNase H cleavage are used as primers for plus-strand DNA synthesis. Nonnucleoside RT inhibitors (NNRTIs) can interfere with the initiation of plus-strand DNA synthesis by enhancing PPT removal, while HIV RT connection subdomain mutations N348I and N348I/T369I mitigate this effect by altering RNase H cleavage specificity. Now, we demonstrate that among approved nonnucleoside RT inhibitors (NNRTIs), nevirapine and doravirine show the largest effects. The combination N348I/T369I in HIV-1BH10 RT has a dominant effect on the RNase H cleavage specificity at the PPT/U3 site. Biochemical studies showed that wild-type HIV-1 and HIV-2 RTs were able to process efficiently and accurately all tested HIV PPT sequences. However, the cleavage accuracy at the PPT/U3 junction shown by the HIV-2EHO RT was further improved after substituting the sequence YQEPFKNLKT of HIV-1BH10 RT (positions 342–351) for the equivalent residues of the HIV-2 enzyme (HQGDKILKV). Our results highlight the role of β-sheets 17 and 18 and their connecting loop (residues 342–350) in the connection subdomain of the large subunit, in determining the RNase H cleavage window of HIV RTs., This research was funded by the Spanish Ministry of Science and Innovation (grants BIO2016-76716-R (AEI/FEDER, UE), and PID2019-104176RB-I00/AEI/10.13039/501100011033), and an institutional grant of Fundación Ramón Areces (Madrid, Spain) to the CBMSO. J.L. was a postdoctoral fellow of the Juan de la Cierva program, funded by the Spanish Ministry of Economy and Competitiveness (grant FJCI-2015-23564). S.M.-A. is a predoctoral fellow of the Spanish Ministry of Science and Innovation (BES-2017-079836). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Design, synthesis and biological evaluation of 3-hydroxyquinazoline-2,4(1H,3H)-diones as dual inhibitors of HIV-1 reverse transcriptase-associated RNase H and integrase

  • Gao, Ping
  • Cheng, Xiqiang
  • Sun, Lin
  • Song, Shu
  • Álvarez, Mar
  • Luczkowiak, Joanna
  • Pannecouque, Christophe
  • De Clercq, Erik
  • Menéndez-Arias, Luis
  • Zhan, Peng
  • Liu, Xinyong
A novel series of 3-hydroxyquinazoline-2,4(1H,3H)-diones derivatives has been designed and synthesized. Their biochemical characterization revealed that most of the compounds were effective inhibitors of HIV-1 RNase H activity at sub to low micromolar concentrations. Among them, II-4 was the most potent in enzymatic assays, showing an IC50 value of 0.41 ± 0.13 μM, almost five times lower than the IC50 obtained with β-thujaplicinol. In addition, II-4 was also effective in inhibiting HIV-1 IN strand transfer activity (IC50 = 0.85 ± 0.18 μM) but less potent than raltegravir (IC50 = 71 ± 14 nM). Despite its relatively low cytotoxicity, the efficiency of II-4 in cell culture was limited by its poor membrane permeability. Nevertheless, structure-activity relationships and molecular modeling studies confirmed the importance of tested 3-hydroxyquinazoline-2,4(1H,3H)-diones as useful leads for further optimization., Financial support from the National Natural Science Foundation of China (NSFC No. 81273354), the Key Project of NSFC for International Cooperation (No. 81420108027), the Key Research and Development Project of Shandong Province (No. 2017CXGC1401), the Young Scholars Program of Shandong University (YSPSDU No. 2016WLJH32, to P. Z.), the Major Project of Science and Technology of Shandong Province (No. 2015ZDJS04001) is gratefully acknowledged. Work in Madrid was supported by grant BIO2016-76716-R (AEI/FEDER, UE) (Spanish Ministry of Economy, Industry and Competitiveness) and an institutional grant of Fundación Ramón Areces. The technical assistance of Mr. Kris Uyttersprot, and Mrs. Kristien Erven, for the HIV experiments is gratefully acknowledged., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Otros (Other)

An Update on Antiretroviral Therapy

  • Menéndez-Arias, Luis
  • Martín-Alonso, Samara
  • Frutos-Beltrán, Estrella
Human immunodeficiency virus (HIV) infection and acquired immune deficiency syndrome (AIDS) still claim many lives across the world. However, research efforts during the last 40 years have led to the approval of over 30 antiretroviral drugs and the introduction of combination therapies that have turned HIV infection into a chronic but manageable disease. In this chapter, we provide an update on current available drugs and treatments, as well as future prospects towards reducing pill burden and developing long-acting drugs and novel antiretroviral therapies. In addition, we summarize efforts to cure HIV, including pharmaceutical strategies focused on the elimination of the virus., This work was supported by grants of the Ministry of Science and Innovation of Spain (BIO2016-76716-R (AEI/FEDER, UE) and PID2019-104176RB-I00/AEI/10.13039/501100011033 awarded to L.M.-A.), and CSIC (2019AEP001 awarded to L.M.-A.). S.M.-A. is a predoctoral fellow of the Ministry of Science and Innovation of Spain (BES-2017-079836). An institutional grant of the Fundación Ramón Areces to the CBMSO is also acknowledged., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Transcriptional inaccuracy threshold attenuates differences in RNA-dependent DNA synthesis fidelity between retroviral reverse transcriptases

  • Sebastián-Martín, Alba
  • Barrioluengo, Verónica
  • Menéndez-Arias, Luis
In M13mp2 lacZα forward mutation assays measuring intrinsic fidelity of DNA-dependent DNA synthesis, wild-type human immunodeficiency virus type 1 (HIV-1) RTs of group M/subtype B previously showed >10-fold higher error rates than murine leukaemia virus (MLV) and avian myeloblastosis virus (AMV) RTs. An adapted version of the assay was used to obtain error rates of RNA-dependent DNA synthesis for several RTs, including wild-type HIV-1BH10, HIV-1ESP49, AMV and MLV RTs, and the high-fidelity mutants of HIV-1ESP49 RT K65R and K65R/V75I. Our results showed that there were less than two-fold differences in fidelity between the studied RTs with error rates ranging within 2.5 × 10-5 and 3.5 × 10-5. These results were consistent with the existence of a transcriptional inaccuracy threshold, generated by the RNA polymerase while synthesizing the RNA template used in the assay. A modest but consistent reduction of the inaccuracy threshold was achieved by lowering the pH and Mg2+ concentration of the transcription reaction. Despite assay limitations, we conclude that HIV-1BH10 and HIV-1ESP49 RTs are less accurate when copying DNA templates than RNA templates. Analysis of the RNA-dependent mutational spectra revealed a higher tendency to introduce large deletions at the initiation of reverse transcription by all HIV-1 RTs except the double-mutant K65R/V75I., This work was supported by grants of the Spanish Ministry of Economy and Competitiveness (BIO2013–48788-C2-1-R and BIO2016-76716-R (AEI/FEDER, UE)), and an institutional grant of the Fundación Ramón Areces. A. S.-M. is a recipient of a predoctoral fellowship of the Spanish Ministry of Education, Culture and Sport (FPU2013-00693)., Peer reviewed